Hefei Lifeon Pharmaceutical (003020.SZ): The timolol maleate eye drops have obtained the pharmaceutical registration certificate.

On April 22, Gelonghui reported that Hefei Lifeon Pharmaceutical (003020.SZ) announced that it recently received the drug registration certificate issued by the National Medical Products Administration for Timolol Maleate Eye Drops. Timolol Maleate Eye Drops are used in ophthalmology to reduce intraocular pressure, suitable for treating ocular hypertension and glaucoma. The Timolol Maleate Eye Drops for which the company obtained the drug registration certificate are classified as Chemical Drug registration Category 3 (domestically filed applications for the imitation of overseas marketed but not marketed original drugs), with quality and efficacy consistent with the reference formulation.

Gelonghui FinanceApr 22 06:08 ET

Cube Pharmaceuticals: 2024 Annual Report Summary

SZSIApr 21 12:00 ET · Announcements

Cube Pharmaceuticals: first quarter report 2025

SZSIApr 21 12:00 ET · Announcements

Cube Pharmaceuticals: 2024 Annual Report

SZSIApr 21 12:00 ET · Announcements

Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Shares Leap 32% Yet They're Still Not Telling The Full Story

Simply Wall StApr 17 18:38 ET

Insiders Were the Biggest Winners as Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Market Cap Grew by CN¥396m Last Week

Simply Wall StApr 15 20:52 ET